Introduction: Several studies have shown that a dentist’s gender and nationality are important factors for patients when they choose their dentist. This topic is important in countries like Saudi Arabia, which is considered to be conservative and has many cultural boundaries that separate men from women in daily activities. Aim: This study aimed to investigate patient preference for a dentist’s gender among a sample population in Jeddah, Saudi Arabia. Methods: This cross-sectional study recruited 1,000 participants who completed a self-administered questionnaire. Data were analyzed using SPSS v.21. Results: A total of 46.2% of the participants had no particular gender preference for dentists in general, while 28.6% prefered male dentists and 25.2% prefered female dentists. Male and female participants had statistically significant differences in the selection of a dentist’s gender in general, with all participants tending to choose a dentist of the same gender as themselves. Previous personal experience and recommendations from friends were among the most influential factors in choosing dentists of a specific gender. In terms of preferences for dentists of a particular nationality, 45.6% had no preferences, while 28.4% preferred Saudi dentists. Conclusion: Although half of the Jeddah residents participating in our study had no preference for dentists of a particular gender or nationality, the other half had specific preferences.
Background. Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic relapsing disease indicated by inflammation of the gastrointestinal tract. Celiac disease (CeD) is a chronic autoimmune disease of the small bowel. The prevalence of CeD in IBD patients is unknown. Some studies have described the coexistence of the 2 diseases in the same patient. This study aimed to investigate the prevalence of CeD in Saudi Arabian children with IBD. Methods. We used a retrospective study design because data can be collected immediately and is easier to analyze afterward. The study was conducted on IBD patients in the Pediatric Gastroenterology Department at National Guard Hospital, Jeddah, Saudi Arabia. We enrolled Saudi patients aged between 1 and 18 years who had been diagnosed with IBD and CeD based on positive biochemical serology and histology from January 2011 to January 2020. We excluded patients with immunodeficiency disorders. Results. Among the 46 enrolled patients with IBD, CeD was identified in 4, and they did not develop any relapses. We discovered that the weight at IBD diagnosis improved significantly compared to current weight ( P-value < .0001). We also discovered that the height at diagnosis of IBD improved significantly compared to the current height ( P-value < .0001). Additionally, we found no significant associations between UC and CeD ( P-value = 1), or CD and CeD ( P-value = .625). Conclusion. No significant associations were evident between the prevalence of CeD and IBD. More prospective multicenter studies are needed to clarify the prevalence of CeD in children with IBD.
Organ transplantation is the best and often times the only opportunity for patients with end-stage organ disease to survive. In 1985, the Kingdom of Saudi Arabia was one of the few Arab countries to have started an organ donation program. The program was later expanded and renamed the Saudi Center for Organ Transplantation (SCOT) in 1994. This chapter reviews the literature around organ donation and transplantation and introduces the different types of consent and registries available from different parts of the world as a solution for enhancing the process of donation and increasing organ donation rates. It also explores the organ donation process, the role of the SCOT program, and the social and public factors that influence organ donation in Saudi Arabia.
PurposeCentral nervous system (CNS) involvement in non‐Hodgkin lymphoma (NHL) is well‐known, occurring in approximately 10% of all cases. Among these, infiltrative lymphomatous optic neuropathy (LON) affects 5% usually in the setting of active CNS disease. However, isolated LON in relapsed NHL remains exceptionally rare. Herein, we present a unique case of sequential bilateral optic nerve infiltration as the sole manifestation of relapsed T‐cell lymphoblastic lymphoma.MethodsCase report.ResultsA 30‐year‐old male patient diagnosed as a case of mediastinal T‐cell lymphoblastic lymphoma (LBL).Staging CT confirmed no other site was involved. He received chemotherapy as per protocol. Re‐evaluation with chest CT showed complete resolution of the mass. Five weeks later, the patient presented to private hospital complaining of right eye pain with blurred vision and by the fifth day his vision deteriorated to no light perception. He was diagnosed as relapsed LBL with isolated right optic nerve infiltration and treated accordingly. Two months later, he presented to our center for the first time with left eye pain and blurred vision. Full eye examination revealed blind right eye with no perception of light. Retinal examination for right eye was consistent with combined retinal artery and vein occlusion. Left eye fundus examination revealed gross swelling of the optic disc. Brain MRI showed swollen left optic nerve with no mass occupying lesion. He was treated promptly with radiotherapy and planed for re‐induction chemotherapy.ConclusionsOptic nerve infiltration represents an ocular emergency where timely diagnosis and intervention can prevent the irreversible loss of vision. Ophthalmologists should keep high index of suspicion and consider prompt through eye examinations along with brain imaging in patients with history of lymphoma presenting with visual complaints.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.